However, when the PSA density threshold was set at 0.15, omitting biopsies for patients with a PSA decrease greater than 20% helped reduce unnecessary biopsies by 16.4% and the diagnosis of clinically non-significant cancer by 9.1%, without increasing the rate of missed csPCa (1-sensitivity). Here, KLK3 is linked to cancer.